On Thursday, the Biden-Harris administration declared that ten of the most costly and frequently prescribed medications under the Medicare program will have their costs reduced.
According to the US Department of Health and Human Services, Medicare prescription price discounts range from 38% to 79% off list costs.
According to the federal agency, had the new costs for the ten medications been in place the previous year, Medicare would have saved $6 billion (£4.7 billion).
The following information relates to the negotiated drugs:
Which ten medications does Medicare negotiate?
For people with Medicare prescription drug coverage, the negotiated costs will take effect on January 1, 2026.
The ten medications are listed below, together with the agreed-upon cost for a month’s supply:
Diabetes is treated with Januvia. The agreed-upon price is $113 (£103), a 79% decrease.
NovoLog, NovoLog FlexPen, NovoLog PenFill, Fiasp, Fiasp FlexTouch, and NovoLog PenFill: Diabetes is treated with these pharmaceuticals, which are insulin medications. The agreed-upon price is $119, a 76% decrease.
Diabetes, heart failure, and chronic renal illness are all treated with Farxiga. The agreed-upon price is $178.50, a 68% decrease.
Psoriasis, psoriatic arthritis, and rheumatoid arthritis are all treated with Enbrel. Down 67%, the negotiated price is $2,355.
Diabetes, heart failure, and chronic renal disease are all treated with Jardiance. The agreed-upon price is $197, a 66% reduction.
